Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
88 participants
OBSERVATIONAL
2026-01-01
2027-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluating a Chronic Pain Treatment Program
NCT00861302
Resilience Skills Self-Management for Chronic Pain.
NCT03304613
Study to Understand Pain Experiences in Relationships
NCT02859545
Acute Pain Assessment Using Facial Expression Analysis
NCT03957967
Positive Psychology for Chronic Pain Self-management
NCT04321239
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Evaluation of the potential link between emotional intelligence and chronic orofacial pain.
All included subjects will have the same participation, which consists of completing several standardized questionnaires. These questionnaires assess various psychological and emotional aspects, including anxiety and depressive disorders (HADS questionnaire), coping strategies (Brief-COPE score), emotional regulation (ERS score), fatigue level (EVA scale), and emotional intelligence (TEIQue-SF questionnaire) to compare scores between the DTM group and the control group. Additionally, sociodemographic and psychosocial criteria will be collected to refine the analysis of the results. The completion of these questionnaires is part of routine consultations and does not alter the patients' standard care.
Questionnaire and Physical Exam
All included subjects will be required to complete the following questionnaires:
Hospital Anxiety and Depression Scale (HADS) Brief-COPE for coping assessment Emotion Reactivity Scale (ERS) for emotional regulation Visual Analog Scale (VAS) for fatigue assessment Sociodemographic and psychosocial evaluation Trait Emotional Intelligence Questionnaire - Short Form (TEIQue-SF) for emotional intelligence assessment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaire and Physical Exam
All included subjects will be required to complete the following questionnaires:
Hospital Anxiety and Depression Scale (HADS) Brief-COPE for coping assessment Emotion Reactivity Scale (ERS) for emotional regulation Visual Analog Scale (VAS) for fatigue assessment Sociodemographic and psychosocial evaluation Trait Emotional Intelligence Questionnaire - Short Form (TEIQue-SF) for emotional intelligence assessment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Major subject
* Non-opposition obtained
* For subjects in the TMD group:
Diagnosis of temporomandibular dysfunction -No other diagnosis of chronic pain
For subjects in the control group:
-No diagnosis of chronic pain
* Subject not understanding French
* Subject under legal protection (guardianship or curatorship)
* Refusal to participate
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Brest
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025-A00682-47
Identifier Type: REGISTRY
Identifier Source: secondary_id
29BRC24.0372
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.